Skip to main content
. 2019 Jun 19;8(13):e010150. doi: 10.1161/JAHA.118.010150

Table 1.

Description of the Study Population at Follow‐Up (N=1809)

Parameter Mean (SD), Median (min, max), or Percent
Age, y 17.6 (4.5)
Sex (% female) 49.5
Race/Ethnicity (%)
Non‐Hispanic white 76.2
Non‐Hispanic black 9.7
Hispanic 11.8
Other 2.4
Duration of T1DM, y 7.8 (1.9)
Height, m 1.7 (0.1)
Weight, kg 66.5 (19.6)
Waist‐to‐height ratio 0.5 (0.1)
Body mass index, kg/m2 23.9 (5.2)
Body mass index (z score) AUC 0.6 (0.9)
Systolic blood pressure, mm Hg 106.0 (11.0)
Systolic blood pressure (z score) AUC −0.4 (0.9)
Diastolic blood pressure, mm Hg 68.4 (8.9)
Diastolic blood pressure (z score) AUC 0.0 (1.1)
MAP (z score) AUC 78.3 (7.4)
Heart rate, bpm 69.5 (11.7)
Total cholesterol, mg/dL 169.7 (34.8)
LDL‐cholesterol, mg/dL 96.2 (28.1)
Triglycerides, mg/dL 73.0 (17.0, 992.0)
HDL‐cholesterol, mg/dL 55.2 (13.6)
HDL‐cholesterol (mg/dL) AUC 56.0 (11.7)
Non–HDL‐cholesterol, mg/dL 114.4 (34.7)
Non–HDL‐cholesterol (mg/dL) AUC 109.4 (26.3)
Fasting glucose, mg/dL 212.8 (92.2)
Insulin dose (units/kg of body weight per day) 0.9 (0.4)
Glycated hemoglobin, % 9.1 (1.8)
Glycated hemoglobin (%) AUC 8.5 (1.3)
C‐reactive protein, mg/dL 0.1 (0.0, 7.9)

AUC indicates area under the curve; HDL, high‐density lipoprotein; LDL, low‐density lipoprotein; MAP, mean arterial pressure; T1DM, type 1 diabetes mellitus.